GLOBAL

CARDIAC RHYTHM MANAGEMENT (CRM) DEVICES MARKET GROWTH ANALYSIS, 2009-2015

CURRENT TRENDS, ESTIMATES AND FORECASTS, MARKET GROWTH ANALYSIS 2009-2015
PUBLICATION:FEBRUARY,2011|REPORTCODE:ARMMR116 REPORTPRICE:$4260|NO.OFPAGES:700 TABLES/CHARTS:408

GEOGRAPHICCOVERAGE
NORTHAMERICA EUROPE ASIAPACIFIC LATINAMERICA& RESTOFWORLD

PRIMARILYFOCUSESON:
LATESTMARKETTRENDS REGIONWISEDEMANDFACTOR KEYGROWTHAREAS
| Copyright 2011 | All Rights Reserved

MARKETSIZES KEYCOMPETITORSEDGE INVESTMENTSTRATEGIES

GLOBAL CARD G L DIAC RH HYTHM MANAG GEMENT (CRM) DEVIC T ) CES MARK GR KET ROWTH ANALYS 20 SIS, 009-2015
REPORT CODE: A T ARMMR116 6

PUBLISHED: FEBRU UARY, 20 011

REPORT PRICE: $ T $4260

SEGM MENTA ATION

CARD DIAC RH HYHM MAN ANAGEMENT (CRM DEVI RM) ICES

CAR RDIAC DE EFIBRIL LLATORS S IM MPLANTAB CARD BLE DIOVERTE ER DE EFIBRILLA ATORS (IC CD) EX XTERNAL DEFIBRIL LLATING DE EVICES CAR RDIAC PA ACEMAK KERS IM MPLANTAB PACE BLE EMAKERS EX XTERNAL PACEMAK KERS CAR RDIAC RES SYNCHR RONIZATI ION THE ERAPY (C CRT) CA ARDIAC RE ESYNCHR RONIZATI ION TH HERAPY D DEFIBRILL LATOR (CR RT-D) CA ARDIAC RE ESYNCHR RONIZATI ION PA ACEMAKE (CRT-P ERS P) SUR RGICAL A ABLATIO ON OTH HERS

KEY COMP PANIES PROF S FILED

MEDT TRONIC, INC. AGA MEDICAL COR RPORATION CARD DIACASSIST, INC. COOK GROUP INC CORPORATED ABBOTT VA ASCULAR DEV VICES ATRICURE, INC , CARDICA, INC. CORDIS CO ORPORATION ABIOM MED, INC. ATRIU MEDICAL C UM CORP. IDEV T TECHNOLOGIE ES CRYOL LIFE INC. ADVA ANSOURCE BIOMATERIALS ATS M MEDICAL, INC C. CARD DIOMEMS, INC C. &m many more

BIOP PHAN TECHNO OLOGIES, INC. BIOSENSE W . WEBSTER, INC C.

BOSTO SCIENTIFIC CORP CARD ON C DIAC SCIENCE CORP. E

Copyright 2011 | Axis Research Mind | All Rights Reserved

GLOBAL CARDIAC RHYTHM MANAGEMENT (CRM) DEVICES MARKET GROWTH ANALYSIS, 2009-2015
REPORT CODE: ARMMR116

PUBLISHED: FEBRUARY, 2011

REPORT PRICE: $4260

REPORT FOCUS
The report Global Cardiac Rhythm Management (CRM) Devices - Market Growth Analysis, 2009-2015 reviews the latest trends in the CRM devices market with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs), government organizations and many more in preferred locations. Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates. Estimates have incorporated recessionary impact on the cardiac devices industry. Anticipating a protracted recovery towards 2011, we have used CAGR to forecast 2011-2015 figures. More than 608 leading market players are identified and 82 key companies in cardiac medical devices industry that project improved market activities in the near future are profiled. The report consists of 408 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.

Global market watch

Copyright 2011 | Axis Research Mind | All Rights Reserved

The broad health care division has been witnessing a rapid growth and technological improvements varying from sector to sector since the past 3-5 years. The evolution of cardiac devices has opened new vistas in the health care industry. Growth rate exhibited by the cardiac devices industry, even during the recession years, confirms the positive growth prospects going ahead. Global Cardiac Rhythm Management Devices (CRM) market forecasts to reach at US$22.3 billion by 2015 at a CAGR of 9.3% during the analysis period 2009-2015. The North American segment accounts for nearly 40% of the global value while Europe claims approximately 30% of the market. Asia-Pacific is the fastest growing region with a CAGR of 11.1% driving a market value of US$5.5 billion by 2015. On a global scale, projections for External Defibrillators market value indicate less than half of Implantable Cardioverter Defibrillators by 2015. External pacemakers market value forecasts show a 40% by 2015 leaving the rest of the market to the implantable pacemakers. Cardiac CRT devices market forecasts to reach at US$2.8 billion by 2015 at a CAGR of 10% during the analysis period and projections for CRT defibrillators market value suggest 45% by 2015 leaving the rest of the market to the CRT pacemakers and other similar devices.

GETTING THE MOST FROM OUR RESEARCH ANALYSIS

GLOBAL CARDIAC RHYTHM MANAGEMENT (CRM) DEVICES MARKET GROWTH ANALYSIS, 2009-2015
REPORT CODE: ARMMR116

PUBLISHED: FEBRUARY, 2011

REPORT PRICE: $4260

Geographic coverage
Incorporating the recession impacts on the industry, the market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually for the upcoming years. The Global Coverage of Cardiac Rhythm Management (CRM) Devices Market is North America, Europe, AsiaPacific, Latin America and Rest of World with 19 countries, analyzed individually as follows: NORTH AMERICA USA AND CANADA EUROPE UNITED KINGDOM, GERMANY, FRANCE, ITALY, SPAIN, RUSSIA, BELGIUM AND REST OF EUROPE ASIA-PACIFIC JAPAN, CHINA, INDIA, NEW ZEALAND, SOUTH KOREA, AUSTRALIA AND REST OF ASIA-PACIFIC LATIN AMERICA BRAZIL, ARGENTINA & REST OF LATIN AMERICA REST OF THE WORLD SOUTH AFRICA, MIDDLE EAST & REST OF REST OF WORLD

Key Activities in the Cardiac devices MARKET

BIOTRONIK SE AND CO. KG EARNED THE CARDIOSTIM INNOVATION AWARD CE MARK FOR CORMATRIX ECM FOR CARDIAC TISSUE REPAIR PROMRI PACING SYSTEM PORTFOLIO RELEASED BY BIOTRONIK FDA CLEARANCE FOR ATRICUREATRICLIP SYSTEM CONDITIONAL FDA APPROVAL FOR HEARTWARE VENTRICULAR ASSIST SYSTEM FDA CLEARANCE FOR CRYOLIFECRYOVALVE SG PULMONARY HEART VALVE ATRIUM HONORED BY PREMIER HEALTHCARE ALLIANCE FOR EXCEEDING PERFORMANCE EXPECTATIONS BD CRITICAL CARE SYSTEMS TO BE ACQUIRED BY ARGON MEDICAL DEVICES SORIN GROUP TAKES OVER GISH BIOMEDICAL INTERVENTIONAL CONFIGURATION TO ASSIST IN STROKE ASSESSMENT BY PHILIPS NEW HYBRID ECG CORE LAB FOR PHASE I CLINICS INTRODUCED BY CELERION

& many more..

www.axisresearchmind.com